Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

c-Cbl is a critical modulator of the Ron tyrosine kinase receptor

Abstract

Ron, the receptor tyrosine kinase (RTK) for the macrophage stimulating protein (MSP), activates multiple signaling pathways by recruiting several positive regulators to a multifunctional docking site. Here we show that stimulation by MSP also recruits a negative regulator, the c-Cbl ubiquitin ligase, to the multifunctional docking site as well as to a juxtamembrane tyrosine autophosphorylation site. c-Cbl recruitment to these two sites results in polyubiquitylation of Ron molecules, which are subsequently sorted for endocytosis and degradation. Both the phosphotyrosine binding domain of c-Cbl and its RING domain are essential for downregulation of Ron. Although Ron and c-Cbl are found also in physical complexes that include Grb2, these associations are insufficient for productive ubiquitylation of Ron. Our results shed light on the mechanism of receptor desensitization mediated by c-Cbl and its binding partner Grb2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Chen YQ, Fisher JH and Wang MH . (1998). J. Immunol., 161, 4950–4959.

  • Chen YQ, Zhou YQ, Angeloni D, Kurtz AL, Qiang XZ and Wang MH . (2000). Exp. Cell Res., 261, 229–238.

  • Comoglio PM and Trusolino L . (2002). J. Clin. Invest., 109, 857–862.

  • Correll PH, Iwama A, Tondat S, Mayrhofer G, Suda T and Bernstein A . (1997). Genes Funct., 1, 69–83.

  • Danilkovitch A, Skeel A and Leonard EJ . (1999). Exp. Cell Res., 2, 575–582.

  • Danilkovitch-Miagkova A and Leonard EJ . (2001). Apoptosis, 6, 183–190.

  • Feshchenko EA, Langdon WY and Tsygankov AY . (1998). J. Biol. Chem., 273, 8323–8331.

  • Feshchenko EA, Shore SK and Tsygankov AY . (1999). Oncogene, 25, 3703–3715.

  • Fournier TM, Lamorte L, Maroun CR, Lupher M, Band H, Langdon W and Park M . (2000). Mol. Biol. Cell, 11, 3397–3410.

  • Garcia-Guzman M, Larsen E and Vuori K . (2000). Oncogene, 19, 4058–4065.

  • Gaudino G, Follenzi A, Naldini L, Collesi C, Santoro M, Gallo KA, Godowski PJ and Comoglio PM . (1994). EMBO J., 13, 3524–3532.

  • Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T and Liu YC . (1999). Science, 286, 309–312.

  • Keane MM, Ettenberg SA, Nau MM, Banerjee P, Cuello M, Penninger J and Lipkowitz S . (1999). Oncogene, 18, 3365–3375.

  • Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC and Lipkowitz S . (1995). Oncogene, 10, 2367–2377.

  • Lee PS, Wang Y, Dominguez MG, Yeung YG, Murphy MA, Bowtell DD and Stanley ER . (1999). EMBO J., 18, 3616–3628.

  • Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S and Yarden Y. (1999). Mol. Cell, 4, 1029–1040.

  • Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B and Yarden Y . (1998). Genes Dev., 12, 3663–3674.

  • Li BQ, Wang MH, Kung HF, Ronsin C, Breathnach R, Leonard EJ and Kamata T . (1995). Biochem. Biophys. Res. Commun., 216, 110–118.

  • Lupher Jr ML, Songyang Z, Shoelson SE, Cantley LC and Band H . (1997). J. Biol. Chem., 272, 33140–33144.

  • Maggiora P, Marchio S, Stella MC, Giai M, Belfiore A, De Bortoli M, Di Renzo MF, Costantino A, Sismondi P and Comoglio PM . (1998). Oncogene, 16, 2927–2933.

  • Meisner H, Conway BR, Hartley D and Czech MP . (1995). Mol. Cell Biol., 15, 3571–3578.

  • Meisner H, Daga A, Buxton J, Fernandez B, Chawla A, Banerjee U and Czech MP . (1997). Mol. Cell Biol., 17, 2217–2225.

  • Meng F and Lowell CA . (1998). EMBO J., 17, 4391–4403.

  • Miyake S, Mullane-Robinson KP, Lill NL, Douillard P and Band H . (1999). Biol. Chem., 274, 16619–16628.

  • Morrison AC and Correll PH . (2002). J. Immunol., 168, 853–860.

  • Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon W and Park M . (2001). Mol. Cell, 8, 995–1004.

  • Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N and Giordano S . (2002). Nature, 416, 187–190.

  • Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G and Comoglio PM . (1994). Cell, 77, 261–271.

  • Santoro MM, Penengo L, Minetto M, Orecchia S, Cilli M and Gaudino G . (1998). Oncogene, 17, 741–750.

  • Thien CB and Langdon WY . (2001). Nat. Rev. Mol. Cell Biol., 2, 294–307.

  • Thien CB, Walker F and Langdon WY . (2001). Mol. Cell., 7, 355–365.

  • Wang MH, Ronsin C, Gesnel M-C, Coupey L, Skeel A, Leonard EJ and Breathnach R . (1994). Science, 266, 117–119.

  • Waterman H, Katz M, Rubin C, Shtiegman K, Lavi S, Elson A, Jovin T and Yarden Y et al. (2002). EMBO J., 21, 303–313.

  • Waterman H, Levkowitz G, Alroy I and Yarden Y . (1999). J. Biol. Chem., 274, 22151–22154.

  • Weidner KM, Di Cesare S, Sachs M, Brinkmann V, Behrens J and Birchmeier W . (1996). Nature, 384, 173–176.

  • Yoon CH, Lee J, Jongeward GD and Stemberg PW . (1995). Science, 269, 1102–1105.

Download references

Acknowledgements

This work was supported by grants from AIRC and COFIN-PRIN. LP was supported by EMBO fellowship ASTF 17.02.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giovanni Gaudino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Penengo, L., Rubin, C., Yarden, Y. et al. c-Cbl is a critical modulator of the Ron tyrosine kinase receptor. Oncogene 22, 3669–3679 (2003). https://doi.org/10.1038/sj.onc.1206585

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206585

Keywords

This article is cited by

Search

Quick links